Active ingredientRetapamulinCat. No. P-R043-001CAS 224452-66-8Family · Pharmaceutical analytical standards
Retapamulin
A topical antibiotic of the pleuromutilin family, which blocks bacterial protein synthesis by binding the ribosome at a site different from other antibiotics; approved in 2007 in the United States for impetigo. This family brings together the active ingredient and other impurities.
Did you know?It derives from pleuromutilin, discovered in 1951 in the fungus Pleurotus mutilus, which gave it its name; after the veterinary derivatives tiamulin and valnemulin, it was the first antibiotic of this family approved for humans.
Go to the active ingredient →Active ingredientRetapamulinCat. No. P-R043-001CAS 224452-66-8
ImpurityRetapamulin Impurity 1Cat. No. P-R043-005
ImpurityRetapamulin Impurity 2Cat. No. P-R043-006
ImpurityRetapamulin Impurity 3Cat. No. P-R043-007
ImpurityRetapamulin Impurity 4Cat. No. P-R043-008
ImpurityRetapamulin Impurity 5Cat. No. P-R043-011
ImpurityRetapamulin Impurity 6Cat. No. P-R043-012CAS 35136-87-9
ImpurityRetapamulin Impurity 7Cat. No. P-R043-013
ImpurityRetapamulin O-Methyl sulphateCat. No. P-R043-015
ImpurityRetapamulin sulfoxideCat. No. P-R043-016No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.